Skip to main content

FDA pharmacologic class

Amide Local Anesthetic

5 medicines are in FDA's class of amide local anesthetics: lidocaine (Xylocaine), bupivacaine (Exparel), ropivacaine (Naropin), mepivacaine (Carbocaine) and prilocaine (Citanest); 8 combination products also contain one. 9 of the 13 are listed from generic labelers (FDA NDC Directory, October 8, 2026). The lowest pharmacy cost is bupivacaine 0.5% vial at $0.086 per mL (NADAC).

Which medicines are amide local anesthetic?

Recalls: FDA enforcement reports, 2012 on
MedicineBrand namesGeneric labelers (all forms)Pharmacy costBoxed warningShortageRecalls since 2012
LidocaineXylocaine, Lidoderm, Ztlido81 labelers$0.154 per gram 5% ointmentNoIn shortage39
BupivacaineMarcaine, Sensorcaine, Exparel26 labelers$0.086 per mL 0.5% vialYesIn shortage17
RopivacaineNaropin18 labelersn/aNoIn shortage4
Epinephrine and lidocaineXylocaine, Xylocaine-Mpf, Flavalta17 labelers$0.139 per mL 1%-epi 1:100,000NoIn shortage9
Articaine and epinephrineOrablocnone listedn/aNoNo current entry1
Bupivacaine and epinephrineSensorcaine, Marcaine5 labelersn/aYesNo current entry10
Lidocaine and prilocaineOraqix12 labelers$0.232 per gram 2.5%-2.5% creamNoNo current entry1
MepivacainePolocaine, Polocaine-Mpf, Scandonest12 labelersn/aNoNo current entry5
Dextrose and lidocainenone listednone listedn/aNoListed; available0
Bupivacaine and meloxicamZynrelefnone listedn/aYesNo current entry1
Epinephrine and prilocaineCitanest2 labelersn/aNoNo current entry0
Lidocaine and tetracainePliaglisnone listedn/aNoNo current entry1
PrilocaineCitanest1 labelern/aNoNo current entry0

Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)

What do pharmacies pay?

Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.

Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price

What next?